Liquidia proclaimed positive Phase1 and Preclinical results for LIQ861 for treatment of PAH Read more
Evofem Biosciences enrolls first patient in Phase 2b/3 Clinical Trial assessing Amphora’s ability to foil UCG in women Read more
ProMIS Neurosciences claimed further results of previously claimed Preclinical program for Alzheimer’s Disease Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients Read more
Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies Read more